Tag Archives: seeking-alpha

Transport ETFs Modestly Up On Q3 Earnings

Unlike the second quarter, the transportation sector is headed for a solid Q3 earnings season, lagging only auto. This is especially true as total earnings from 97.8% of the sector’s total market capitalization reported are up 22.5% while revenues declined 1.2%. This is much better than Q2 earnings growth of 9.4% and revenue decline of 1.9% for the same period. Further, earnings surprises were predominantly solid with 84.6% of the companies beating earnings estimates and 30.8% beating on revenues compared with earnings and revenue beat ratios of 58.3% and 8.3%, respectively for Q2. For a better understanding, let’s dig into earnings results of some well-known industry players: Transportation Earnings in Focus The world’s largest package delivery company – United Parcel Service (NYSE: UPS ) – beat our earnings estimate by a couple of cents but revenues of $14.2 billion fell shy of our estimate of $14.35 billion. The company now expects earnings per share on the high end of the previous guidance of $5.05-$5.30 for fiscal 2015, which represents 6-12% growth on an annual basis. The Zacks Consensus Estimate at the time of earnings release was pegged at $5.27. Union Pacific (NYSE: UNP ) , the U.S. largest railroad, reported earnings of $1.50 per share outpacing the Zacks Consensus Estimate by seven cents but revenues of $5.56 billion fell short of our estimate of $5.65 billion. Other major railroads like CSX Corp. (NYSE: CSX ) and Kansas City Southern (NYSE: KSU ) also missed on revenues. At CSX, revenues lagged the Zacks Consensus Estimate by $68 million while at KSU revenues missed by $8 million. However, CSX outpaced our earnings estimate by couple of cents while KSU missed our earnings estimate by a penny. Ryder Systems (NYSE: R ) , the leader in supply chain management and fleet management services, topped the bottom line but lagged the top line. Earnings per share of $1.74 came above the Zacks Consensus Estimate of $1.72 while revenues of $1.67 billion were below our estimate of $1.72 billion. The two largest U.S. airlines – Delta Air Lines (NYSE: DAL ) and United Continental (NYSE: UAL ) – beat our earnings estimates by three cents and four cents, respectively. Revenues for Delta were slightly below the Zacks Consensus Estimate but above for United Continental (read: Highflier Airlines Earnings: Time for JETS ETF ). Last but not the least, earnings for the leading trucking carrier – J.B. Hunt (NASDAQ: JBHT ) – also came in above the Zacks Consensus Estimate by three cents and revenues were $30 million below our estimate. ETFs in Focus Despite the slew of earnings beat, many stocks have seen rough performances. As a result, the transport ETFs has been modestly up over the past 15 days. Both the iShares Dow Jones Transportation Average Fund (NYSEARCA: IYT ) and the SPDR S&P Transportation ETF (NYSEARCA: XTN ) are up 0.4% and 0.2%, respectively. Both funds have a Zacks ETF Rank of 3 or ‘Hold’ rating with a High risk outlook (see: all the Industrials ETFs here ). IYT The fund tracks the Dow Jones Transportation Average Index, giving investors exposure to a small basket of 21 securities. The fund has a certain tilt toward large cap stocks at 49% while mid and small caps account for 31% and 20% share, respectively, in the basket. The product is heavily concentrated on the top firm – FedEx (NYSE: FDX ) – at 11.9%, followed by UPS (8%), UNP (6.8%) and KSU (6.3%). From a sector perspective, air freight & logistics takes the top spot with more than one-fourth of the portfolio while trucking, airlines and railroads round off to the next three spots with double-digit exposure each. The fund has accumulated nearly $965 million in AUM while sees solid trading volume of more than 409,000 shares a day. It charges 43 bps in annual fees. XTN This fund uses an almost equal weight methodology for each security by tracking the S&P Transportation Select Industry Index. Holding 49 stocks in its basket with AUM of $270 million, each security accounts for less than 3.4% of total assets. The ETF is skewed toward small caps at 55% while the rest is evenly split between mid and large caps. About one-third of the portfolio is dominated by trucking, while airlines takes another one-fourth share. Airfreight & logistics, and railroads also make up for a double-digit allocation each. The fund charges 35 bps in fees per year from investors and trades in a moderate volume of nearly 96,000 shares a day. Link to the original post on Zacks.com

Financial Markets Have Not Been Handing Out Participation Trophies

In the financial markets, different asset types are always competing for our investing dollars. Moreover, when a particular asset class like U.S. stocks has only a handful of companies holding up a benchmark like the S&P 500, the probability for a revolt by the collective will of all corporate shares rises immensely. This is precisely what transpired in the August-September sell-off. The internal weakness across components of popular benchmarks like the Russell 1000, S&P 500 and NASDAQ 100 should not be ignored. I watch more football than I should. It may have something to do with the ability to see any game or any highlight on DirecTV in real time. Or perhaps there are few parenting responsibilities with my 19-year old daughter attending college 60 miles south of our Orange County home. Or maybe it’s a semi-conscious desire to avoid working out at the nearby LA Fitness. Regardless, I could barely keep my eyes open during Monday night’s contest between the Colts and the Panthers. Tedious? I thought it was a “Snooze Fest.” I found myself cheering more for a Kia car commercial than the yawn producing match-up on the field. In case you missed the advertisement, the camera focuses in on a father who is beaming with pride. His son’s team has just finished an entire season without losing a single game. The dad asks his child to see the trophy and it reads, “Participant.” Disdainfully, he proceeds to remove the flimsy tag and write in the word, “Champs.” Yes, I am one of those old school thinkers who believes that participation is its own reward and that it does not need to be acknowledged. You should get an “A” for performance, not for effort. You should get a raise for what you bring to a conference table beyond your backside. “Showing up” is not deserving of the same pay, the same grades or the same accolades as those who are achieving more. My ideas of morality and social sensibility notwithstanding, there are times when things still get out of whack. Imagine a classroom where two standouts receive “As” and thirty-two others receive “Fs.” Where are the Bs, Cs and Ds? Chances are, a teacher is failing his/her students. Similarly, picture a company with three executives earning tens of millions and three thousand employees earning minimum wage. Where are the highly compensated folks, the relatively well-paid skilled producers and the modestly compensated workers? In this scenario, the extent of the income inequality is likely to end in revolt. In the financial markets, different asset types are always competing for our investing dollars. Moreover, when a particular asset class like U.S. stocks has only a handful of companies holding up a benchmark like the S&P 500, the probability for a revolt by the collective will of all corporate shares rises immensely. This is precisely what transpired in the August-September sell-off. Market participation (a.k.a. “market breadth”) broke down well in advance of the sell-off. Of course, the October rally has seen participation in a bullish uptrend improve dramatically. Nearly 72% of S&P 500 stocks now exhibit bullish uptrends. That’s not far from the 75% participation that existed in the first five months of 2015. On the other hand, equal-weighted ETFs continuing to warn that things are less than hunky-dory. Consider the performance of the Guggenheim S&P 500 Equal Weight ETF (NYSEARCA: RSP ) at different periods in the current U.S. stock bull. Year-to-date, RSP is underperforming the S&P 500 SPDR Trust ETF (NYSEARCA: SPY ). This suggests that market-cap leading components (e.g., Facebook (NASDAQ: FB ), Apple (NASDAQ: AAPL ), Microsoft (NASDAQ: MSFT ), etc.) have been doing the heavy sledding and that, when one weights all of the companies in the S&P 500 evenly, the bull market is less healthy across the entire landscape than many would like to admit. Now gander at the outperformance of RSP over SPY in the three years prior. During the three-year run (2012-2014), strong gains across the participant components of the S&P 500 indicated a broader willingness to take risk than in the present environment. Ironically, the circumstances within the NASDAQ 100 are eerily similar. Take a look at the performance of the First Trust NASDAQ-100 Equal Weight Index ETF (NASDAQ: QQEW ) versus the PowerShares QQQ Trust ETF (NASDAQ: QQQ ) at different periods. Year-to-date, QQEW is underperforming QQQ. Once again, this is evidence of less-than-ideal participation. During the three years prior, however, QQEW kept pace with QQQ. The relative underperformance of equal-weighted ETFs can be observed across numerous sectors as well. Year-to-date since the summertime, the G uggenheim S&P Equal Weight Technology ETF (NYSEARCA: RYT ) is struggling relative to the market-cap weighted Technology Select Sector SPDR ETF (NYSEARCA: XLK ). Less participation (a.k.a. less market breadth) is typically an undesirable omen. Once again, take note of the healthier participation in the previous three years. None of these observations definitively prove that the current rally is doomed in the near-term. On the contrary. As discussed last in last week’s commentary on our current allocation for moderate growth and income clients , we embraced the successful retest of the August lows for SPY and QQQ in late September. We bumped the 50% equity component up to 60%, which is roughly 5% shy of a 65-35 standard. That said, the internal weakness across components of popular benchmarks like the Russell 1000, S&P 500 and NASDAQ 100 should not be ignored. If that weakness intensifies, as it did in in May, June and July of 2015, we would likely raise cash levels as we did in the summertime. What’s more, investors should keep in mind that bond investors are still somewhat skeptical about the sustainability of the stock rally beyond calendar year 2015. The spread between high yield (BBB) and comparable treasuries is still elevated and the spread is still greater than what it was in mid-September. (click to enlarge) For Gary’s latest podcast, click here . Disclosure: Gary Gordon, MS, CFP is the president of Pacific Park Financial, Inc., a Registered Investment Adviser with the SEC. Gary Gordon, Pacific Park Financial, Inc, and/or its clients may hold positions in the ETFs, mutual funds, and/or any investment asset mentioned above. The commentary does not constitute individualized investment advice. The opinions offered herein are not personalized recommendations to buy, sell or hold securities. At times, issuers of exchange-traded products compensate Pacific Park Financial, Inc. or its subsidiaries for advertising at the ETF Expert web site. ETF Expert content is created independently of any advertising relationships.

Valuation Dashboard: Healthcare – November 2015

Summary 4 key factors are reported across industries in the Healthcare sector. They give a valuation status of industries relative to their history. They give a reference for picking stocks in each industry. This article is part of a series giving a valuation dashboard by sector of companies in the S&P 500 index (NYSEARCA: SPY ). I follow up a certain number of fundamental factors for every sector, and compare them to historical averages. This article is going down at industry level in the GICS classification. It covers Healthcare. The choice of the fundamental ratios has been justified here and here . You can find in this article numbers that may be useful in a top-down approach. There is no analysis of individual stocks. A link to a list of individual stocks to consider is provided at the end. Methodology Four industry factors calculated by portfolio123 are extracted from the database: Price/Earnings (P/E), Price to sales (P/S), Price to free cash flow (P/FCF), Return on Equity (ROE). They are compared with their own historical averages “Avg”. The difference is measured in percentage for valuation ratios and in absolute for ROE, and named “D-xxx” if xxx is the factor’s name (for example D-P/E for price/earnings). The industry factors are proprietary data from the platform. The calculation aims at eliminating extreme values and size biases, which is necessary when going out of a large cap universe. These factors are not representative of capital-weighted indices. They are useful as reference values for picking stocks in an industry, not for ETF investors. Industry valuation table on 11/2/2015 The next table reports the 4 industry factors. For each factor, the next “Avg” column gives its average between January 1999 and October 2015, taken as an arbitrary reference of fair valuation. The next “D-xxx” column is the difference as explained above. So there are 3 columns for each ratio. P/E Avg D- P/E P/S Avg D- P/S P/FCF Avg D- P/FCF ROE Avg D-ROE HC Equipment&Supplies 34.5 27.18 -26.93% 4.12 3.18 -29.56% 45.64 30.51 -49.59% -20.09 -12.14 -7.95 HC Providers&Services 28.81 20.88 -37.98% 1.09 0.85 -28.24% 22.4 17.75 -26.20% 7.46 5.78 1.68 HC Technology* 56.41 56.13 -0.50% 4.11 3.39 -21.24% 32.35 35.77 9.56% -15.66 -6.2 -9.46 Biotechnology 47.8 39.78 -20.16% 50.92 29.01 -75.53% 41.33 43.74 5.51% -62.42 -64.42 2 Pharmaceuticals 32.96 26.26 -25.51% 12.28 8.25 -48.85% 29.82 32.55 8.39% -38.03 -30.3 -7.73 Life Sci. Tools&Services* 31.78 29.52 -7.66% 2.89 3.39 14.75% 32.39 27.28 -18.73% -8.87 -18.37 9.5 * Averages since 2006 Valuation The following charts give an idea of the current status of industries relative to their historical average. In all cases, the higher the better. Price/Earnings: Price/Sales: Price/Free Cash Flow: Quality Relative Momentum The next chart compares the price action of the SPDR Select Sector ETF (NYSEARCA: XLV ) with SPY (chart from freestockcharts.com). It also includes the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ) and the SPDR S&P Pharmaceuticals ETF (NYSEARCA: XPH ) as industry benchmarks. (click to enlarge) Conclusion The broad Healthcare ETF has almost the same return as SPY in the last 6 months, with large discrepancies between industries. The biotechnology index has underperformed by about 4%, the pharmaceutical index by about 14%. Two series of news have hit the latter: political announcements on overpriced legacy drugs initiated by Mrs Clinton, then suspicions of unduly inflated sales involving specialty pharmacies. Valeant Pharmaceuticals Intl (NYSE: VRX ) is at the core of both cases, but the market has punished most names linked to generic drugs and specialty pharmaceutical products. As it includes hedge fund darlings, an ETF replicating famous managers’ holdings has also suffered from this: the AlphaClone Alternative Alpha ETF ( ALFA). Taking into account valuation charts above, all healthcare industries look overpriced. There is no contradiction with the positive value score reported for Healthcare in my latest S&P 500 sector dashboard . Here, mid and small caps have been added in calculations. It is a clue of a significant discrepancy between market cap segments inside the sector. The most influential valuation factor from a statistical point of view is P/FCF, and it is more optimistic than other ratios. It points out to a slight under-pricing in 3 industries: Healthcare Technology, Biotechnology and Pharmaceuticals. However, there may be quality stocks at a reasonable price in any industry. To check them out, you can compare individual fundamental factors to the industry factors provided in the table. As an example, a list of stocks in Healthcare beating their industry factors is provided on this page . If you want to stay informed of my updates, click the “Follow” tab at the top of this article. You can choose the “real-time” option if you want to be instantly notified.